Burning Rock Biotech Limited (BNR) — Stock Score Summary

Burning Rock Biotech Limited (BNR) has a MoatMap StockRank of 29/100 based on Quality (46/100), Value (52/100), and Momentum (18/100) factor scores. The current signal is SELL. An unprofitable cancer diagnostics company in China. It has high cash burn and lacks a clear path to sustainable profitability, failing our fundamental quality and margin of safety screens.

Burning Rock Biotech Limited is a Chinese biotechnology company specializing in next-generation sequencing (NGS) diagnostics for oncology therapy selection and early cancer detection. The company holds a leading position in China's NGS-based cancer diagnostics market, driven by its robust hospital-admission model and regulatory approvals. Burning Rock is a prominent precision medicine player actively developing multi-cancer early detection technologies for global clinical applications.

Key Financial Metrics

Price$8.18
Market Cap$107M
P/E (Forward)-15.79
Price/Book1.22
Return on Equity-9.9%
Return on Invested Capital-9.4%
Debt/Equity8.06
Gross Margin74.7%
Operating Margin-9.5%
Revenue Growth0.2%
Free Cash Flow$-23M

Burning Rock Biotech Limited operates in the Diagnostics & Research industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Burning Rock Biotech Limited’s (BNR) StockRank?
MoatMap’s StockRank for Burning Rock Biotech Limited (BNR) is 29/100, with a Sell signal. It is a composite of Quality (46), Value (52), and Momentum (18) factor ranks across MoatMap’s 19,000+ stock universe.
Does Burning Rock Biotech Limited have an economic moat?
Burning Rock Biotech Limited (BNR) has a Quality factor score of 46/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Burning Rock Biotech Limited a buy, hold, or sell?
MoatMap’s current signal for Burning Rock Biotech Limited (BNR) is Sell, based on a StockRank of 29/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Burning Rock Biotech Limited in?
Burning Rock Biotech Limited (BNR) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).
Browse all ranked stocksBNR deep dive reportAI ChampionsHow we score stocksSense-check another stock